109 related articles for article (PubMed ID: 32830201)
21. Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk.
Liu J; Prager-van der Smissen WJ; Schmidt MK; Collée JM; Cornelissen S; Lamping R; Nieuwlaat A; Foekens JA; Hooning MJ; Verhoef S; van den Ouweland AM; Hogervorst FB; Martens JW; Hollestelle A
Sci Rep; 2016 Jul; 6():30026. PubMed ID: 27424772
[TBL] [Abstract][Full Text] [Related]
22. Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy.
Schroeck FR; Zuhlke KA; Siddiqui J; Siddiqui R; Cooney KA; Wei JT
J Urol; 2013 Mar; 189(3):849-53. PubMed ID: 23036981
[TBL] [Abstract][Full Text] [Related]
23. Mutation HOXB13 c.853delT in Martinican prostate cancer patients.
Marlin R; Créoff M; Merle S; Jean-Marie-Flore M; Rose M; Malsa S; Promeyrat X; Martin F; Comlan G; Rabia N; Taouil T; Issoufaly I; Escarmant P; Vinh-Hung V; Béra O
Prostate; 2020 May; 80(6):463-470. PubMed ID: 32040869
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.
Beebe-Dimmer JL; Isaacs WB; Zuhlke KA; Yee C; Walsh PC; Isaacs SD; Johnson AM; Ewing CE; Humphreys EB; Chowdhury WH; Montie JE; Cooney KA
BJU Int; 2014 May; 113(5):830-5. PubMed ID: 24148311
[TBL] [Abstract][Full Text] [Related]
25. HOXB13 mutation and prostate cancer: studies of siblings and aggressive disease.
Witte JS; Mefford J; Plummer SJ; Liu J; Cheng I; Klein EA; Rybicki BA; Casey G
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):675-80. PubMed ID: 23396964
[TBL] [Abstract][Full Text] [Related]
26. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.
Johng D; Torga G; Ewing CM; Jin K; Norris JD; McDonnell DP; Isaacs WB
Prostate; 2019 Mar; 79(4):414-424. PubMed ID: 30560549
[TBL] [Abstract][Full Text] [Related]
27. Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours.
FitzGerald LM; Raspin K; Marthick JR; Field MA; Malley RC; Thomson RJ; Blackburn NB; Banks A; Charlesworth JC; Donovan S; Dickinson JL
Sci Rep; 2017 Dec; 7(1):17778. PubMed ID: 29259341
[TBL] [Abstract][Full Text] [Related]
28. Germline homeobox B13 (HOXB13) G84E mutation and prostate cancer risk in European descendants: a meta-analysis of 24,213 cases and 73, 631 controls.
Shang Z; Zhu S; Zhang H; Li L; Niu Y
Eur Urol; 2013 Jul; 64(1):173-6. PubMed ID: 23518396
[No Abstract] [Full Text] [Related]
29. Genetic factors influencing prostate cancer risk in Norwegian men.
Chen H; Ewing CM; Zheng S; Grindedaal EM; Cooney KA; Wiley K; Djurovic S; Andreassen OA; Axcrona K; Mills IG; Xu J; Maehle L; Fosså SD; Isaacs WB
Prostate; 2018 Feb; 78(3):186-192. PubMed ID: 29181843
[TBL] [Abstract][Full Text] [Related]
30. Population-based estimate of prostate cancer risk for carriers of the HOXB13 missense mutation G84E.
MacInnis RJ; Severi G; Baglietto L; Dowty JG; Jenkins MA; Southey MC; Hopper JL; Giles GG
PLoS One; 2013; 8(2):e54727. PubMed ID: 23457453
[TBL] [Abstract][Full Text] [Related]
31. Germline HOXB13 p.Gly84Glu mutation and cancer susceptibility: a pooled analysis of 25 epidemiological studies with 145,257 participates.
Cai Q; Wang X; Li X; Gong R; Guo X; Tang Y; Yang K; Niu Y; Zhao Y
Oncotarget; 2015 Dec; 6(39):42312-21. PubMed ID: 26517352
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer.
Alanee S; Shah S; Vijai J; Schrader K; Hamilton R; Rau-Murthy R; Sarrel K; Manschreck C; Eastham J; Offit K
Fam Cancer; 2013 Dec; 12(4):597-600. PubMed ID: 23475555
[TBL] [Abstract][Full Text] [Related]
33. Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer.
Akbari MR; Anderson LN; Buchanan DD; Clendenning M; Jenkins MA; Win AK; Hopper JL; Giles GG; Nam R; Narod S; Gallinger S; Cleary SP
Cancer Epidemiol; 2013 Aug; 37(4):424-7. PubMed ID: 23541221
[TBL] [Abstract][Full Text] [Related]
34. The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland.
Kluźniak W; Wokołorczyk D; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Gołąb A; Gliniewicz B; Sikorski A; Switała J; Borkowski T; Borkowski A; Antczak A; Wojnar L; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała P; Akbari MR; Lubiński J; Narod SA; Cybulski C;
Prostate; 2013 Apr; 73(5):542-8. PubMed ID: 23334858
[TBL] [Abstract][Full Text] [Related]
35. A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.
Darst BF; Hughley R; Pfennig A; Hazra U; Fan C; Wan P; Sheng X; Xia L; Andrews C; Chen F; Berndt SI; Kote-Jarai Z; Govindasami K; Bensen JT; Ingles SA; Rybicki BA; Nemesure B; John EM; Fowke JH; Huff CD; Strom SS; Isaacs WB; Park JY; Zheng W; Ostrander EA; Walsh PC; Carpten J; Sellers TA; Yamoah K; Murphy AB; Sanderson M; Crawford DC; Gapstur SM; Bush WS; Aldrich MC; Cussenot O; Petrovics G; Cullen J; Neslund-Dudas C; Kittles RA; Xu J; Stern MC; Chokkalingam AP; Multigner L; Parent ME; Menegaux F; Cancel-Tassin G; Kibel AS; Klein EA; Goodman PJ; Stanford JL; Drake BF; Hu JJ; Clark PE; Blanchet P; Casey G; Hennis AJM; Lubwama A; Thompson IM; Leach RJ; Gundell SM; Pooler L; Mohler JL; Fontham ETH; Smith GJ; Taylor JA; Brureau L; Blot WJ; Biritwum R; Tay E; Truelove A; Niwa S; Tettey Y; Varma R; McKean-Cowdin R; Torres M; Jalloh M; Magueye Gueye S; Niang L; Ogunbiyi O; Oladimeji Idowu M; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Yeboah ED; Mensah JE; Anthony Adjei A; Diop H; Cook MB; Chanock SJ; Watya S; Eeles RA; Chiang CWK; Lachance J; Rebbeck TR; Conti DV; Haiman CA
Eur Urol; 2022 May; 81(5):458-462. PubMed ID: 35031163
[TBL] [Abstract][Full Text] [Related]
36. Germline mutations in HOXB13 and prostate-cancer risk.
Ewing CM; Ray AM; Lange EM; Zuhlke KA; Robbins CM; Tembe WD; Wiley KE; Isaacs SD; Johng D; Wang Y; Bizon C; Yan G; Gielzak M; Partin AW; Shanmugam V; Izatt T; Sinari S; Craig DW; Zheng SL; Walsh PC; Montie JE; Xu J; Carpten JD; Isaacs WB; Cooney KA
N Engl J Med; 2012 Jan; 366(2):141-9. PubMed ID: 22236224
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of the HOXB13 G84E mutation among unaffected men with a family history of prostate cancer.
Handorf E; Crumpler N; Gross L; Giri VN
J Genet Couns; 2014 Jun; 23(3):371-6. PubMed ID: 24310616
[TBL] [Abstract][Full Text] [Related]
38. HOXB13 mutations in a population-based, case-control study of prostate cancer.
Stott-Miller M; Karyadi DM; Smith T; Kwon EM; Kolb S; Stanford JL; Ostrander EA
Prostate; 2013 May; 73(6):634-41. PubMed ID: 23129385
[TBL] [Abstract][Full Text] [Related]
39. The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients.
Na R; Wei J; Sample CJ; Gielzak M; Choi S; Cooney KA; Rabizadeh D; Walsh PC; Zheng LS; Xu J; Isaacs WB
Br J Cancer; 2022 Mar; 126(5):791-796. PubMed ID: 34799695
[TBL] [Abstract][Full Text] [Related]
40. The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer.
Akbari MR; Kluźniak W; Rodin R; Li S; Wokołorczyk D; Royer R; Kashyap A; Menkiszak J; Lubinski J; Narod SA; Cybulski C
Breast Cancer Res Treat; 2012 Dec; 136(3):907-9. PubMed ID: 23099437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
